Yohimbine promotes cardiac NE release and prevents LPS-induced cardiac dysfunction via blockade of presynaptic α2A-adrenergic receptor
about
Pathophysiology of sepsis-induced myocardial dysfunctionInhibition of mTORC1 renders cardiac protection against lipopolysaccharide.DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4.β₁-adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis through activating PKA and enhancing CaMKII and IκBα phosphorylation.Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts.Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia ratsParticipation of α2 -adrenoceptors in sodium appetite inhibition during sickness behaviour following administration of lipopolysaccharide.Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats.Anesthetic Propofol-Induced Gene Expression Changes in Patients Undergoing Coronary Artery Bypass Graft Surgery Based on Dynamical Differential Coexpression Network Analysis.Dexmedetomidine ameliorates the inflammatory immune response in rats with acute kidney damagePropofol protects against endotoxin-induced myocardial injury by inhibiting NF-κB-mediated inflammation.α2A-adrenergic blockade attenuates septic cardiomyopathy by increasing cardiac norepinephrine concentration and inhibiting cardiac endothelial activation.
P2860
Q28079058-401C82E3-BAE5-4913-A247-D1192562755DQ35038438-A5B773D8-D297-4573-858E-FCB892B76290Q35098869-00046A12-1D23-42A8-972F-D923625B943EQ35247702-F0241AD3-CB57-44A6-B38C-1ABA99EBA13FQ35532344-C938F6EA-FE4B-4E82-B981-3CA8F74CDEC7Q35741960-410F2766-3F59-436D-9FAA-D431C211D2A1Q38513417-38E9B367-8F77-492D-A482-4C964B1C7B21Q41658137-AE9F7D55-F844-448F-B38C-EF7B3B9CACE2Q42054354-0020FB41-832B-4B1E-819C-4FB186CDDAFAQ42376449-14EE7161-283C-4A71-B5D1-850C1449F6CCQ49643828-A6402E56-441C-4285-8886-C61C9C97B6EFQ55339088-42CF888C-D513-45DD-AFBF-4696FA66A789
P2860
Yohimbine promotes cardiac NE release and prevents LPS-induced cardiac dysfunction via blockade of presynaptic α2A-adrenergic receptor
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@ast
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@en
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@nl
type
label
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@ast
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@en
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@nl
prefLabel
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@ast
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@en
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@nl
P2093
P2860
P1433
P1476
Yohimbine promotes cardiac NE ...... naptic α2A-adrenergic receptor
@en
P2093
Daxiang Lu
Faqiang Wang
Hongmei Li
Huadong Wang
Xiaohui Yu
Yanping Wang
Yiyang Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0063622
P407
P577
2013-05-14T00:00:00Z